Johnson Matthey (LON:JMAT) Releases Earnings Results

Johnson Matthey (LON:JMAT – Get Free Report) posted its earnings results on Thursday. The company reported GBX 102.20 EPS for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 720.60 billion for the quarter. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%.

Here are the key takeaways from Johnson Matthey’s conference call:

  • Johnson Matthey upgraded its FY2026/27 outlook to high-single-digit growth in underlying operating profit, excluding Catalyst Technologies and Cormetech at constant currency and metal prices. It also expects a £35 million benefit from metal prices and around £20 million of operating contribution from Cormetech.
  • Clean Air delivered strong growth: operating profit rose 26% and margins increased 180 basis points to 14.2%. Management expects further margin progress and reiterated its 16%–18% margin target for 2027/28, while noting that market volumes will influence where it lands within that range.
  • The new Clean Power business is gaining momentum, with its revenue outlook raised to at least £250 million and margins expected to be at least mid-teens. Its order book for Cormetech through March 2028 has reached £350 million, although the business is benefiting heavily from current U.S. data-center demand.
  • First-half free cash flow was a £98 million outflow, mainly due to temporary working-capital needs around a U.S. refinery stock take. Management expects that working capital to unwind in the second half and full-year free cash flow to exceed last year’s £168 million; it also reiterated plans for at least £200 million of shareholder returns annually.
  • Full ramp-up of the new U.K. PGM refinery has shifted from calendar 2027 to early 2028, with management expecting modest additional CapEx. Hydrogen Technologies revenue also fell 26% and is expected to remain soft in the second half, though the company still targets break-even operating profit for the year.

Johnson Matthey Price Performance

Shares of JMAT opened at GBX 2,374 on Thursday. The business has a 50-day moving average of GBX 2,395.10 and a 200-day moving average of GBX 2,156.14. The company has a debt-to-equity ratio of 69.69, a current ratio of 1.56 and a quick ratio of 0.76. The company has a market capitalization of £2.95 billion, a price-to-earnings ratio of -31.13, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.88. Johnson Matthey has a 1 year low of GBX 2,192 and a 1 year high of GBX 3,245.33.

Insider Transactions at Johnson Matthey

In related news, insider Liam Condon acquired 10,951 shares of the stock in a transaction dated Friday, September 11th. The stock was purchased at an average cost of GBX 2,306 per share, with a total value of £252,530.06. Also, insider Richard Pike purchased 17,635 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were acquired at an average cost of GBX 2,248 per share, with a total value of £396,434.80. Insiders have bought a total of 28,628 shares of company stock worth $64,999,052 in the last three months. Insiders own 0.78% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on JMAT. Berenberg Bank raised their price target on shares of Johnson Matthey from GBX 2,300 to GBX 2,550 and gave the stock a “buy” rating in a research report on Wednesday, October 28th. Jefferies Financial Group reissued a “buy” rating and set a GBX 2,770 target price on shares of Johnson Matthey in a research note on Thursday, November 12th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of GBX 2,458.

Read Our Latest Research Report on JMAT

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Featured Stories

Earnings History for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.